Tomoko Hirohashi

3.2k total citations
29 papers, 2.5k citations indexed

About

Tomoko Hirohashi is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Tomoko Hirohashi has authored 29 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Tomoko Hirohashi's work include Drug Transport and Resistance Mechanisms (13 papers), Pediatric Hepatobiliary Diseases and Treatments (7 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Tomoko Hirohashi is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Pediatric Hepatobiliary Diseases and Treatments (7 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Tomoko Hirohashi collaborates with scholars based in Japan, United States and Italy. Tomoko Hirohashi's co-authors include Yuichi Sugiyama, Hiroshi Suzuki, Kazuhiko Kume, Kousei Ito, Hajime Takikawa, Takao Shimizu, Yuichi Sugiyama, Hirotoshi Suzuki, Hiroshi Suzuki and Charles A. Tyson and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and FEBS Letters.

In The Last Decade

Tomoko Hirohashi

28 papers receiving 2.5k citations

Peers

Tomoko Hirohashi
Peter J. Meier Switzerland
Marie V. St–Pierre Switzerland
F Thiébaut United States
Léa Payen France
P.J. Meier Switzerland
Miyuki Shimane Japan
Asuka Oku Japan
Lu-Bin Lan United States
Maria L.H. Vlaming Netherlands
Sierk Haenisch Germany
Peter J. Meier Switzerland
Tomoko Hirohashi
Citations per year, relative to Tomoko Hirohashi Tomoko Hirohashi (= 1×) peers Peter J. Meier

Countries citing papers authored by Tomoko Hirohashi

Since Specialization
Citations

This map shows the geographic impact of Tomoko Hirohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Hirohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Hirohashi more than expected).

Fields of papers citing papers by Tomoko Hirohashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Hirohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Hirohashi. The network helps show where Tomoko Hirohashi may publish in the future.

Co-authorship network of co-authors of Tomoko Hirohashi

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Hirohashi. A scholar is included among the top collaborators of Tomoko Hirohashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Hirohashi. Tomoko Hirohashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirohashi, Tomoko, J. Thaddeus Beck, Jessica D. McDermott, et al.. (2023). Trials in progress: TAM kinase inhibitor PF-07265807 and sasanlimab plus axitinib in patients with advanced or metastatic renal cell carcinoma—A phase 1, open-label, pharmacokinetic, safety and tolerability study.. Journal of Clinical Oncology. 41(6_suppl). TPS743–TPS743. 2 indexed citations
2.
Lee, Kyung-Hun, Toshihiko Doi, Tae Min Kim, et al.. (2013). Phase I study (A8471004) in Asian patients of PF-03446962, a fully human mab against ALK-1 receptor involved in tumor angiogenesis: Safety, pharmacokinetics (PK), and pharmacodynamics (PD).. Journal of Clinical Oncology. 31(15_suppl). 11031–11031. 1 indexed citations
3.
Yoshino, Takayuki, Kentaro Yamazaki, Tetsuya Hamaguchi, et al.. (2012). Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancer.. PubMed. 32(3). 973–9. 6 indexed citations
4.
Takahashi, Toshiyuki, Yuji Haga, Toshihiro Sakamoto, et al.. (2009). Aryl urea derivatives of spiropiperidines as NPY Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(13). 3511–3516. 13 indexed citations
5.
Sakamoto, Toshihiro, Minoru Moriya, Toshiyuki Takahashi, et al.. (2009). Novel orally active NPY Y5 receptor antagonists: Synthesis and structure–activity relationship of spiroindoline class compounds. Bioorganic & Medicinal Chemistry. 17(14). 5015–5026. 10 indexed citations
6.
Takahashi, Toshiyuki, Tomoko Hirohashi, Takunobu Shibata, et al.. (2006). Novel potent neuropeptide Y Y5 receptor antagonists: Synthesis and structure–activity relationships of phenylpiperazine derivatives. Bioorganic & Medicinal Chemistry. 14(22). 7501–7511. 27 indexed citations
7.
Hida, Takayuki, Eiki Takahashi, Tomoko Hirohashi, et al.. (2006). Chronic Intracerebroventricular Administration of Relaxin-3 Increases Body Weight in Rats. Journal of Receptors and Signal Transduction. 26(3). 147–158. 79 indexed citations
8.
Sagane, Koji, Kazuhiro Hayakawa, Tomoko Hirohashi, et al.. (2005). Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice. BMC Neuroscience. 6(1). 33–33. 125 indexed citations
9.
Sato, Nagaaki, Takunobu Shibata, Makoto Jitsuoka, et al.. (2004). Synthesis and evaluation of substituted 4-alkoxy-2-aminopyridines as novel neuropeptide Y1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(7). 1761–1764. 3 indexed citations
10.
Akita, Hidetaka, Hiroshi Suzuki, Tomoko Hirohashi, Hajime Takikawa, & Yuichi Sugiyama. (2002). Transport Activity of Human MRP3 Expressed in Sf9 Cells: Comparative Studies with Rat MRP3. Pharmaceutical Research. 19(1). 34–41. 106 indexed citations
11.
Hirohashi, Tomoko, Hiroshi Suzuki, Hajime Takikawa, & Yuichi Sugiyama. (2000). ATP-dependent Transport of Bile Salts by Rat Multidrug Resistance-associated Protein 3 (Mrp3). Journal of Biological Chemistry. 275(4). 2905–2910. 264 indexed citations
12.
Ogawa, Kotaro, Hiroshi Suzuki, Tomoko Hirohashi, et al.. (2000). Characterization of inducible nature of MRP3 in rat liver. American Journal of Physiology-Gastrointestinal and Liver Physiology. 278(3). G438–G446. 203 indexed citations
13.
Gotoh, Yukiko, Hideo Suzuki, Satoshi Kinoshita, et al.. (2000). Involvement of an Organic Anion Transporter (Canalicular Multispecific Organic Anion Transporter/Multidrug Resistance-Associated Protein 2) in Gastrointestinal Secretion of Glutathione Conjugates in Rats. Journal of Pharmacology and Experimental Therapeutics. 292(1). 433–439. 126 indexed citations
14.
Hirohashi, Tomoko, Hiroshi Suzuki, Xiaoyan Chu, et al.. (2000). Function and Expression of Multidrug Resistance-Associated Protein Family in Human Colon Adenocarcinoma Cells (Caco-2). Journal of Pharmacology and Experimental Therapeutics. 292(1). 265–270. 171 indexed citations
15.
Morikawa, Akiko, Yasumasa Goto, Hiroshi Suzuki, Tomoko Hirohashi, & Yuichi Sugiyama. (2000). Biliary Excretion of 17β-Estradiol 17β-d-Glucuronide Is Predominantly Mediated by cMOAT/MRP2. Pharmaceutical Research. 17(5). 546–552. 54 indexed citations
16.
Hirohashi, Tomoko, Hiroshi Suzuki, & Yuichi Sugiyama. (1999). Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3). Journal of Biological Chemistry. 274(21). 15181–15185. 287 indexed citations
17.
Suzuki, Hiroshi, et al.. (1998). cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)1. FEBS Letters. 433(1-2). 149–152. 173 indexed citations
18.
Ito, Kousei, Hiroshi Suzuki, Tomoko Hirohashi, et al.. (1998). Functional Analysis of a Canalicular Multispecific Organic Anion Transporter Cloned from Rat Liver. Journal of Biological Chemistry. 273(3). 1684–1688. 99 indexed citations
19.
Ito, Kousei, Hirotoshi Suzuki, Tomoko Hirohashi, et al.. (1997). Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. American Journal of Physiology-Gastrointestinal and Liver Physiology. 272(1). G16–G22. 251 indexed citations
20.
Morita, Naofumi, Satoshi Toki, Tomoko Hirohashi, et al.. (1995). Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991.. PubMed. 30 Suppl 8. 1–4. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter J. Meier Breakdown of academic impact, for papers by Marie V. St–Pierre Breakdown of academic impact, for papers by F Thiébaut Breakdown of academic impact, for papers by Léa Payen Breakdown of academic impact, for papers by P.J. Meier Breakdown of academic impact, for papers by Miyuki Shimane Breakdown of academic impact, for papers by Asuka Oku Breakdown of academic impact, for papers by Lu-Bin Lan Breakdown of academic impact, for papers by Maria L.H. Vlaming Breakdown of academic impact, for papers by Sierk Haenisch
Rankless by CCL
2026